Leaders In The Excipient Market: Region And Type

By Katie Anderson, Chief Editor, Pharmaceutical Online

The pharmaceutical excipients market is estimated at $9.31 billion in 2025 and expected to  reach $15.43 billion in 2034, according to a recent report by Precedence Research. Though North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.

Pharmaceutical excipients are expected to grow an estimated 5.5% annually from 2025 to 2034. That growth is attributed to a number of factors, including innovation in biologics, as well as plant-based and multifunctional excipients.

Market Leaders

The areas leading the market were North America, Europe, Asia Pacific and Middle East and Africa.

Of these, North America has the highest market share at $3.15 billion in 2024. The U.S. accounted for $3.08 billion of that market share. North America is expecting a 6.04% growth into 2034 to reach $5.66 billion.

Europe led in market share with $2.34 billion in 2034. It is anticipating a 5.30% growth to reach $3.95 billion in 2034.

Asia Pacific is expecting the largest growth from 2024 to 2034, with a 6.53% CAGR from $1.94 billion to $3.65 billion. The reasons fueling this growth are rising exports and generic drug production.

The Middle East and Africa (MEA) pharmaceutical excipients market was valued at $294.40 million in 2024, with an estimated 4.44% growth to reach $454.85 million in 2034.

Excipient Type

The largest market share of excipients was lactose-based excipients, with 41.26%. By functionality, it was fillers and diluents. Coating agents are expected to grow into 2034.

Both bio-based and multifunctional excipients are fueling growth into 2034. Innovative future excipients can control release, make the drugs more tolerable and enhance their bioavailability